Search General Info
Search Education
Search Partnering Companies
![BIO International Convention](/sites/default/files/2021-09/_BIO_CONV_Logo-White.png)
DeepCure is building a different kind of AI biotech company. DeepCure’s AI is harnessing the power of a molecular foundry to synthesize and assay compounds from the world’s largest small molecule library.
DeepCure is a biotech company with preclinical immunology and oncology assets looking for partners to collaborate on current and new small molecule discovery programs.
Deepcure is building a platform that focuses on what drug hunters need. The platform leverages AI to predict binding, selectivity, and other pharmacological properties for optimization, an ultra-large chemical library (10^18 compounds), and a molecular foundry to automate synthesis and assays.
DeepCure was founded at the Massachusetts Institute of Technology (MIT) to accelerate breakthroughs in drug discovery and has raised $47 million from investors, including Morningside. DeepCure is a world-class team of drug discovery and computer scientists headquartered in Boston, MA.
DeepCure is a biotech company with preclinical immunology and oncology assets looking for partners to collaborate on current and new small molecule discovery programs.
Deepcure is building a platform that focuses on what drug hunters need. The platform leverages AI to predict binding, selectivity, and other pharmacological properties for optimization, an ultra-large chemical library (10^18 compounds), and a molecular foundry to automate synthesis and assays.
DeepCure was founded at the Massachusetts Institute of Technology (MIT) to accelerate breakthroughs in drug discovery and has raised $47 million from investors, including Morningside. DeepCure is a world-class team of drug discovery and computer scientists headquartered in Boston, MA.
![](https://778c1607566f28c5e8fd-e6db6de54823ad7fd298e0f6ff75b72a.ssl.cf1.rackcdn.com/BIO_4121_EOISBJNL_478_DeepCureInc-FileId-323354.png)
Company Type:
Privately Funded Company
Company Website:
Company HQ State:
Massachusetts
Company HQ Country:
United States
Year Founded:
2018
Main Therapeutic Focus:
Platform for Therapeutics
Lead Product in Development:
Anti-inflammatory, Anti-fibrotic
Development Phase of Primary Product:
Pre-Clinical
Number Of Unlicensed Products (For Which You Are Seeking Partners):
Not Provided
Speaker
![](https://www.conferenceharvester.com/uploads/harvester/photos/EOISBJNL-Presenter-LimH.png)
BIO DOUBLE HELIX SPONSORS
![Sanofi logo](/sites/default/files/2022-05/Sanofi_Color_jpg_Double%20Helix.jpg)
![Eli Lilly and Company](/sites/default/files/2019-09/Eli%20Lilly%20and%20Company.png)
![Amgen logo](/sites/default/files/2022-05/Amgen_Color_png_Double%20Helix.png)
![Genentech logo](/sites/default/files/2022-05/Genentech_Color_png_Double%20Helix.png)
![Merck_logo_2022](/sites/default/files/2022-10/Merck_Color_.png)
![Avantor](/sites/default/files/2021-06/Avantor-BIO-DH-578.png)
![GSK logo](/sites/default/files/2023-04/gsk_color_png.png)
BIO HELIX SPONSORS
![Johnson and Johnson](/sites/default/files/2021-06/Johnson-Johnson-BIO-DH-578.png)
![Takeda logo](/sites/default/files/2022-05/Takeda_Color_jpg_Premier.jpg)
![Travere logo](/sites/default/files/2022-05/Travere_Color_png_Helix%20large.png)
1201 New York Avenue NW, Suite 1300, Washington, DC, 20005 ・ 202-962-9200
© BIO 2024 All Rights Reserved